| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/28/2008 | WO2008023446A1 Remedy for chronic obstructive pulmonary disease |
| 02/28/2008 | WO2008023063A2 Treatment of cartilage disorders with fgf-18 |
| 02/28/2008 | WO2008023052A1 Combination of a fvii and a thrombin-activable factor x |
| 02/28/2008 | WO2008023050A1 Acylated exendin-4 compounds |
| 02/28/2008 | WO2008022801A1 Method for the manufacture of a medicament for treating hemorrhagic stroke |
| 02/28/2008 | WO2008022800A1 Method for producing condensation products from n-substituted glycine derivatives (peptoids) by sequential ugi-multicomponent reactions |
| 02/28/2008 | WO2008022784A2 Long-lasting absorption of flavonoids |
| 02/28/2008 | WO2008022505A1 Use of rubescensine a and derivatives thereof in pharmacy |
| 02/28/2008 | WO2008022444A1 Small cationic antimicrobial peptides |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | WO2008003925A3 Complement protein |
| 02/28/2008 | WO2008003612A3 Analogs of vasoactive intestinal peptide |
| 02/28/2008 | WO2008003013A3 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 02/28/2008 | WO2007146234A3 Solid oral dosage form containing an enhancer |
| 02/28/2008 | WO2007145539A3 Crystal structure of a substrate complex of miox |
| 02/28/2008 | WO2007140000A3 Administration of the reg1 anticoagulation system |
| 02/28/2008 | WO2007130672B1 Urodilatin cancer treatment |
| 02/28/2008 | WO2007128526A3 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| 02/28/2008 | WO2007127428A3 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery |
| 02/28/2008 | WO2007113837A3 N-terminal vdac variants and uses thereof |
| 02/28/2008 | WO2007112757A3 A process for concentration of a polypeptide |
| 02/28/2008 | WO2007106746A3 Formulations for ecallantide |
| 02/28/2008 | WO2007091159A3 Compositions and methods for treating lysosomal storage diseases |
| 02/28/2008 | WO2007087667A3 Combination preparation for improving sperm quality |
| 02/28/2008 | WO2007084670A8 Specific therapy using integrin ligands for treating cancer |
| 02/28/2008 | WO2007069090A3 Cell penetrating peptides for intracellular delivery of molecules |
| 02/28/2008 | WO2007067812A3 Protein kinase modulation by hops and acacia products |
| 02/28/2008 | WO2007048120A3 Treatment of proliferative disorders with polycationic agents |
| 02/28/2008 | WO2007045450A3 Use of fructanases in feed of hoofed animals to treat and prevent laminitis |
| 02/28/2008 | WO2007022515A3 Stem cell derived factors for treating pathologic conditions |
| 02/28/2008 | WO2007013124A8 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
| 02/28/2008 | WO2006138466A3 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 02/28/2008 | WO2004033637A8 Extracellular messengers |
| 02/28/2008 | US20080051800 Method and device for reducing susceptibility to fractures in vertebral bodies |
| 02/28/2008 | US20080051764 Physiological Monitoring With Continuous Treatment |
| 02/28/2008 | US20080051690 Combination Therapy for Preventing or Treating Alzheimer's Disease, and Kit Therefor |
| 02/28/2008 | US20080051577 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/28/2008 | US20080051561 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080051557 Stable Analogs of Peptide and Polypeptide Therapeutics |
| 02/28/2008 | US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods |
| 02/28/2008 | US20080051490 Medical Devices and Applications of Polyhydroxyalkanoate Polymers |
| 02/28/2008 | US20080051408 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders |
| 02/28/2008 | US20080051359 Antisense oligonucleotide modulation of stat3 expression |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051348 Treatment of infections and other disorders |
| 02/28/2008 | US20080051347 Tumour-associated peptides binding to mhc-molecules |
| 02/28/2008 | US20080051346 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 02/28/2008 | US20080051345 Pharmaceutical compositions comprising fragments and homologs of troponin subunits |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051343 Kits for inducing rapid bone formation; contains bone anabolic agent and a mechanical alteration device for altering contents of a bone marrow cavity |
| 02/28/2008 | US20080051342 TRPS1-mediated modulation of hair growth |
| 02/28/2008 | US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 02/28/2008 | US20080051340 Use of proteins and peptides of the TGF-Beta superfamily for purification and therapeutic methods |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051337 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 02/28/2008 | US20080051336 Relaxin-3 Chimeric Polypeptides and Their Preparation and Use |
| 02/28/2008 | US20080051335 Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers |
| 02/28/2008 | US20080051334 Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases |
| 02/28/2008 | US20080051333 Alpha -defensins (by neutrophils or Paneth cells) is administered to inhibit the post translational processing and release of interleukin-1 beta |
| 02/28/2008 | US20080051332 Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| 02/28/2008 | US20080051330 Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses |
| 02/28/2008 | US20080051329 FSH and FSH variant formulations, products and methods |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use |
| 02/28/2008 | US20080051326 Antiinfective Lipopeptides |
| 02/28/2008 | US20080051325 Oligopeptide |
| 02/28/2008 | US20080051324 Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis |
| 02/28/2008 | US20080051323 Chloroquine drug compositions and methods for their synthesis |
| 02/28/2008 | US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080051320 S-nitrosoprotein preparation and production method therefor |
| 02/28/2008 | US20080051319 Inhibiting JNK Signaling Promotes CNS Axon Regeneration |
| 02/28/2008 | US20080051317 Polypeptides comprising unnatural amino acids, methods for their production and uses therefor |
| 02/28/2008 | US20080051316 Adrenomedullin and Adrenomedullin Binding Protein for Ischemia/Reperfusion Treatment |
| 02/28/2008 | US20080050835 ADH7 nucleic acids |
| 02/28/2008 | US20080050810 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49 |
| 02/28/2008 | US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/28/2008 | US20080050755 Method for screening for chemotherapeutic treatments for cancer |
| 02/28/2008 | US20080050719 Gene expression profiles in liver disease |
| 02/28/2008 | US20080050716 Methods for preserving organs and tissues |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050447 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080050438 Dry compositions |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050429 Low flush niacin formulation |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050415 Polymeric/ceramic composite materials for use in medical devices |
| 02/28/2008 | US20080050414 Methods For Treating Or Preventing Restenosis And Other Vascular Proliferative Disorders |
| 02/28/2008 | US20080050404 Pressure Sore Treatment |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
| 02/28/2008 | US20080050389 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/28/2008 | US20080050387 Non-Androgen Dependent Roles for Androgen Receptor and Non-Androgen Related Inhibitors of Androgen Receptor |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050384 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |